The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial

Nutrition

Volumn 34, Issue , 2017, Pages 7-13

  Barbosa, Milena Maria de Araújo Lima ^a   Melo, Alexandra Lorenzzi Trinanes Raposo de ^a   Damasceno, Nágila Raquel Teixeira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Cardiovascular diseases; Fatty acids; Prevention and control; Randomized controlled trial; Risk factors; 3

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; INSULIN; LEPTIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PLACEBO; SUNFLOWER OIL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SMOKING; BLOOD; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; INSULIN; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 85009084301     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.08.010     Document Type: Article

References (42)

1. [1] Guimarães, D.E.D., Sardinha, F.L., Mizurini, D.M., Carmo, M.G.T., Adipokines: a new view of adipose tissue. Rev Nutr 20 (2007), 549–559.
2. [2] Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999), 79–83.
3. [3] Li, F.Y., Cheng, K.K., Lam, K.S., Vanhoutte, P.M., Xu, A., Cross-talk between adipose tissue and vasculature: Role of adiponectin. Acta Physiol (Oxf) 203 (2011), 167–180.
4. [4] Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Wali, H., Uchida, S., et al. Adiponectin stimulates glucose utilization and fatty-acids oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002), 1288–1295.
5. [5] Rossi, A.S., Lombardo, Y.B., Lacorte, J.M., Chicco, A.G., Rouault, C., Slama, G., et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 289 (2005), R486–R494.
6. [6] Neschen, S., Morino, K., Rossbacher, J.C., Pongratz, R.L., Cline, G.W., Sono, S., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 55 (2006), 924–928.
7. [7] Itoh, M., Suganami, T., Satoh, N., Tanimoto-Koyama, K., Yuan, X., Tanaka, M., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27 (2007), 1918–1925.
8. [8] Lopez-Huertas, E., The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. Br J Nutr 107 (2012), S185–S194.
9. [9] D'Agostino, R.B., Vasan, R.S., Vasan, R.S., Pencina, M.J., Wolf, P.A., Cobain, M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (2008), 743–753.
10. [10] Mosca, L., Benjamin, E.J., Effectiveness-Based Guidelines for the prevention of cardiovascular disease in women 2011 update: a guideline from the American Heart Association. Circulation 123 (2011), 1243–1262.
11. [11] Stone, N.J., Robinson, J., Lichtenstein, A.H., Merz, C.N., Blum, C.B., Eckel, R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), S1–S45.
12. [12] Mohammadi, E., Rafraf, M., Farzadi, L., Asghari-Jafarabadi, M., Sabour, S., Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 21 (2012), 511–518.
13. [13] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
14. [14] Faulin, T.E., Sena, K.C., Telles, A.E., Grosso, D.M., Faulin, E.J., Abdalla, D.S., Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 46 (2008), 1769–1775.
15. [15] Faulin, T.E., Sena-Evangelista, K.C., Pacheco, D.B., Augusto, E.M., Abdalla, D.S., Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes. Clin Chim Acta 413 (2012), 291–297.
16. [16] Stern, S.E., Williams, K., Ferrannini, E., DeFronzo, R.A., Bogardus, C., Stern, M.P., Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54 (2005), 333–339.
17. [17] Bligh, E.G., Dyer, W.J., A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37 (1959), 911–917.
18. [18] Liu, Y.H., Li, X.Y., Chen, C.Y., Zhang, H.M., Kang, J.X., Omega-3 Fatty acid intervention suppresses lipopolysaccharide-induced inflammation and weight loss in mice. Mar Drugs 13 (2015), 1026–1036.
19. [19] Wang, H., Storlien, L.H., Huang, X.F., Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 282 (2002), E1352–E1359.
20. [20] Kabir, M., Skurnik, G., Naour, N., Pechtner, V., Meugnier, E., Rome, S., et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86 (2001), 1670–1679.
21. [21] Defina, L.F., Marcoux, L.G., Devers, S.M., Cleaver, J.P., Willis, B.L., Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 93 (2011), 455–462.
22. [22] Howe, P.R., Buckley, J.D., Murphy, K.J., Pettman, T., Milte, C., Coates, A.M., Relationship between erythrocyte omega-3 content and obesity is gender dependent. Nutrients 6 (2014), 1850–1860.
23. [23] Flachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P., Franssen-Van Hal, N., et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce β-oxidation in white fat. Diabetologia 48 (2005), 2365–2375.
24. [24] Mori, T., Kondo, H., Hase, T., Tokimitsu, I., Murase, T., Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57 BL/6 J mice. J Nutr 137 (2007), 2629–2634.
25. [25] Lottenberg, A.M., Importance of the dietary fat on the prevention and control of metabolic disturbances and cardiovascular disease. Arq Bras Endocrinol Metabol 53 (2009), 595–607.
26. [26] Bueno, A.A., Oyama, L.M., Oliveira, C., Pisani, L.P., Ribeiro, E.B., Silveira, V.L., et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3 T3-L1 cells and C57 BL/6 J mice adipose tissue. Pflugers Arch 455 (2008), 701–709.
27. [27] Stirban, A., Nandrean, S., Götting, C., Stratmann, B., Tschoepe, D., Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm Metab Res 46 (2014), 490–492.
28. [28] Wu, J.H., Cahill, L.E., Mozaffarian, D., Effect of fish oil on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 98 (2013), 2451–2459.
29. [29] Rizza, S., Tesauroa, M., Cardillob, C., Gallia, A., Iantornoc, M., Giglia, F., et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 206 (2009), 569–574.
30. [30] Mostowik, M., Gajos, G., Zalewski, J., Nessler, J., Undas, A., Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease. Cardiovasc Drugs Ther 27 (2013), 289–295.
31. [31] Maia-Fernandes, T., Roncon-Albuquerque, R. Jr., Leite-Moreira, A.F., Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol 27 (2008), 1431–1450.
32. [32] Yamauchi, T., Iwabu, M., Okada-Iwabu, M., Kadowaki, T., Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab 28 (2014), 15–23.
33. [33] Simopoulos, A.P., Genetic variation: nutritional implications. World Rev Nutr Diet 93 (2004), 1–28.
34. [34] Bergqvist, S., Ghosh, G., Komives, E.A., The IkBa/NF-kB complex has two hot spots, one at either end of the interface. Protein Sci 17 (2008), 2051–2058.
35. [35] Novak, T.E., Babcock, T.A., Jho, D.H., Helton, W.S., Espat, N.J., NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol Lung Cell Mol Physiol 284 (2003), L84–L89.
36. [36] Ferré, P., The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes, 53, 2004, S1.
37. [37] Brown, M.S., Goldstein, J.L., The SREBP Pathway: Regulation review of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997), 331–340.
38. [38] Worgall, T.S., Sturley, S.L., Seo, T., Osbornei, T.F., Deckelbaum, R.J., Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem 273 (1998), 25537–25540.
39. [39] Deng, X., Cagen, L.M., Wilcox, H.G., Park, E.A., Raghow, R., Elam, M.B., Regulation of the rat SREBP-1 c promoter in primary rat hepatocytes. Biochem Biophys Res Commun 290 (2002), 256–262.
40. [40] Cesari, M., Narkiewicz, K., De Toni, R., Aldighieri, E., Williams, C.J., Rossi, G.P., Heritability of plasma adiponectin levels and body mass indez in twins. J Clin Endocrinol Metab 92 (2007), 3082–3088.
41. [41] AlSaleh, A., Sanders, T.A., O'Dell, S.D., Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study. Proc Nutr Soc 71 (2012), 141–153.
42. [42] AlSaleh, A., O'Dell, S.D., Frost, G.S., Griffin, B.A., Lovegrove, J.A., Jebb, S.A., et al. Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am J Clin Nutr 94 (2011), 262–269.